selected publications
-
Proceedings of the Ninth HDL (High-Density Lipoprotein) Workshop: Focus on Cardiovascular Disease.
Arteriosclerosis, thrombosis, and vascular biology.
2019
Review
GET IT
Times cited: 7 -
Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability.
Methodist DeBakey cardiovascular journal.
2019
Review
GET IT
Times cited: 14 -
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.
Journal of clinical lipidology.
2018
Review
GET IT
Times cited: 29 - Structural Stability of Streptococcal Serum Opacity Factor. The protein journal. 2017 Academic Article GET IT
-
Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.
The Journal of biological chemistry.
2017
Academic Article
GET IT
Times cited: 25 -
Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms.
Biochemistry.
2016
Academic Article
GET IT
Times cited: 4 - Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo. Biochimica et biophysica acta. 2016 Academic Article GET IT
-
Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.
Methodist DeBakey cardiovascular journal.
2016
Review
GET IT
Times cited: 14 -
Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo.
Biochimica et biophysica acta.
2015
Academic Article
GET IT
Times cited: 4 -
Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism.
Biochemistry.
2015
Academic Article
GET IT
Times cited: 5 -
Alcohol: a nutrient with multiple salutary effects.
Nutrients.
2015
Review
GET IT
Times cited: 8 -
CD1d serves as a surface receptor for oxidized cholesterol induction of peroxisome proliferator-activated receptor-γ.
Atherosclerosis.
2015
Academic Article
GET IT
Times cited: 4 -
ApoE and the role of very low density lipoproteins in adipose tissue inflammation.
Atherosclerosis.
2012
Academic Article
GET IT
Times cited: 21 -
Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.
Arteriosclerosis, thrombosis, and vascular biology.
2011
Academic Article
GET IT
Times cited: 21 -
Speciated human high-density lipoprotein protein proximity profiles.
Biochemistry.
2010
Academic Article
GET IT
Times cited: 24 -
Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol.
Biochemistry.
2010
Academic Article
GET IT
Times cited: 14 -
Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.
Lipids.
2010
Academic Article
GET IT
Times cited: 9 -
Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
Biochemistry.
2009
Academic Article
GET IT
Times cited: 18 -
Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.
Biochemistry.
2009
Academic Article
GET IT
Times cited: 20 -
Role for the BRCA1 C-terminal repeats (BRCT) protein 53BP1 in maintaining genomic stability.
The Journal of biological chemistry.
2003
Academic Article
GET IT
Times cited: 119